• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Butterfly Network Appoints New Leader

    BD Names Chairman of Board

    Interplex Acquires OCP Group

    FDA Clears a Portable Hemodialysis System

    Solid Growth Forecast for India's HER2 Amplification Tests Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.

    maxon

    Medicoil

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    FUTEK Advanced Sensor Technology Inc.

    PTI Engineered Plastics Inc.

    maxon

    K-Tube Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel

    ...

    Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel
    Related CONTENT
    • Empirical Technologies Corp.
    • Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    • Second Sight Appoints Vice President of Research and Development
    • Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?
    • Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market
    Dawn A. Lissy, President & Founder, Empirical05.01.17
    For a company navigating a Class III medical device’s path to market, the U.S. Food and Drug Administration (FDA) panel presentation is the make-or-break point. That’s the day to present a case to convince the FDA that the device—for which there’s no comparable predecessor—is safe and effective enough to be used on patients.

    The buildup to that single day typically takes years. That panel presentation was nine years in the making for Cartiva Inc., a small, venture-backed medical device company. Its 20 employees banked Cartiva’s future on the approval of its initial product to market, the Cartiva Synthetic Cartilage Implant, the first implant of its kind to resurface the metatarsal joint.

    “For your panel meeting, you have that one day,” said Deborah Moore, Cartiva’s vice president of clinical, regulatory, and quality affairs. “It’s eight hours. The future of your company is really made on that particular day. No matter how well we conducted that trial, no matter how good the data was, if we didn’t perform well on that day, it had a significant impact.”

    Those nine years of diligent prep paid off when the implant earned approval in 71 days after the panel presentation. The average timespan for approval is 159 days.

    Moore said finding the right partners to outsource aspects of the device’s development was a critical factor in that success.

    “When we had a critical juncture, we outsourced those aspects,” she said. “The team here was really four individuals who were dedicated to the project. That’s not enough to get to the finish line.”

    Moore contracted with Empirical Testing Corp. for mechanical testing. She turned to Hogan Lovells for legal and strategy support. For regulatory, clinical, and intense panel preparation, she worked with Musculoskeletal Clinical Regulatory Advisers LLC (MCRA). The Washington, D.C.-based full-service consulting firm specializes in musculoskeletal technology.

    Glenn Stiegman, MCRA’s senior vice president of clinical and regulatory affairs, said the right partner knows the landscape of a client’s regulatory path, ideally down to the device’s specific body part and the surgeon installing the device.

    “You want somebody that knows the anatomy and patient population, knows the study design that FDA would expect, knows that review group at the FDA—so you already have that established working relationship,” he said. “You have to understand the dynamics of the whole regulatory and clinical environment.”

    Clients typically outsource to MCRA at three junctures, he said: beginning, middle, and in the wake of a catastrophic event. Cartiva reached out to MCRA in what Stiegman considers to be the middle.

    The firm initially helped strategize responses to FDA’s questions about the device’s clinical study in a major deficiency letter. Over time, MCRA also provided clinical and regulatory strategy and support.

    “We sort of jumped into the deep end since the PMA had been submitted,” Stiegman said. “We came in and said, ‘Let’s do it a different way.’ As time went on, we became more of the face of the company with the FDA.”

    Eventually, Stiegman and other MCRA staffers also became the face of the FDA by playing the role of reviewers for two intense mock panel presentations it helped facilitate for Moore with Hogan Lovells.

    “While a lot of time, strategy, and effort goes into preparing for panel, it’s still a crazy and intense time,” he said. “Being organized and understanding the questions the panel is asking, how best to respond, MCRA played a large role in that. We were working through each question, prepping [Moore] and others on how to respond, the sequence to do it in—MCRA was right by her side.”

    Over the course of the two panel presentation test runs, Moore was grilled intensely. With the help of four more consultants preparing slides, pulling up data, and predicting the line of questioning, she presented her case to surgeons and consultants acting as FDA panel members.

    “It’s one thing to sit in a conference and go back and forth, but to have the questions come from the clinicians at you in the same manner they’d be in the PMA meeting, that was absolutely critical,” she noted.

    Moore said the actual panel presentation was less intense than her two practice runs. Although the mock panels added expenses to her budget, she said the money was “absolutely worth it.”

    “We would do it again,” she said. “But I can see that amount of cost would [give] some companies pause.”

    Finances are certainly a critical consideration for smaller companies, Stiegman said, but costs such as time to market, damage control, and generating sufficient data are also important factors.

    “It’s a tough pill to swallow for a lot of smaller companies,” he said. “A lot of investors don’t get the fact that you have to look at the value creators and being successful at panel—ultimately success with the PMA is a major component, but not the only component. It’s sort of night and day when it comes to the success and the value creation, meaning, get through panel and PMA and you are done. When in reality, with PMA approval, you are just beginning.”

    Not covering all the bases possible can damn the device even if the FDA is satisfied with a panel presentation, Stiegman explained. Data required for reimbursement is a critical consideration that’s become an important factor in device development over the past 10-12 years, he said. It’s an aspect separate from premarket approval, but arguably just as critical to the product’s long-term success.

    “The reimbursement part is sort of behind the curtain all along the process,” Stiegman said of reimbursement concerns on the path to market. “While ideally, the reimbursement data is there in the study from day one, most of the reimbursement data is never going to be reported in a panel setting. That doesn’t fit into safety/effectiveness concerns in [FDA] decision-making.”

    When evaluating a consulting firm’s value, Stiegman advises clients to basically perform a self-audit. They must understand what will be necessary for regulatory approval, reimbursement success, and marketing success. Every device offers different challenges, but he said it comes down to a fundamental question: If cutting a particular expense adds risk to long-term success, is it worth it?

    “If you don’t do it right, it’s more expensive in the long run,” Stiegman said. “You can spend triple the money going through appeals and going back to fix [earlier mistakes]. No one thanks you for saving money if you fail.”  

    Editor’s note: This is the final installment of a three-part series on bringing a Class III medical device to market. Part I, “David vs. Goliath: How a Small Startup Managed to Slingshot the Approval Process” and Part II, “Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market” can be found in the November/December 2016 and January/February 2017 editions of MPO, respectively.


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting, LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio.
    Related Searches
    • pill
    • time to market
    • standards
    • vice president
    Suggested For You
    Empirical Technologies Corp. Empirical Technologies Corp.
    Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    Second Sight Appoints Vice President of Research and Development Second Sight Appoints Vice President of Research and Development
    Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House? Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?
    Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market Smart Outsourcing: Hiring the Team to Get Your Class III Device to Market

    Related Columns

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20


    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20

    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      Having been a part of the medtech supply chain for 40 years, I can say there has never been a more difficult time for supply chain professionals.
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical; CEO, Emergent Respiratory 11.04.20

    • Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.
      Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 11.04.20


    • 3D/Additive Manufacturing
      Additive Manufacturing: Debinding Fluids Must-Haves

      Additive Manufacturing: Debinding Fluids Must-Haves

      As the pressure to produce more complex biomedical parts increases, medical device manufacturing using 3D printing is gaining widespread acceptance.
      Venesia Hurtubise, Technical Chemist, MicroCare Medical 11.04.20

    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Will Industry’s COVID-19 Recovery End Prematurely?

      Will Industry’s COVID-19 Recovery End Prematurely?

      Finally, a light at the end of the tunnel, but will it remain lit?
      Michael Barbella, Managing Editor 10.01.20


    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20

    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Electronics
      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      When looking to outsource the manufacture of electronic medical devices, cleanliness standards and processes should be a top consideration.
      Jay Tourigny, Senior Vice President, MicroCare Medical 10.01.20


    Trending
    • Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Henry Schein Buys Majority Interest In Prism Medical Products
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    Breaking News
    • Butterfly Network Appoints New Leader
    • BD Names Chairman of Board
    • Interplex Acquires OCP Group
    • FDA Clears a Portable Hemodialysis System
    • Solid Growth Forecast for India's HER2 Amplification Tests Market
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    MIND and Mediterranean Diets Linked to Later Onset of Parkinson’s Disease
    Kerry Launches Web-Based Tool for Plant-Based Formulation Challenges
    Coatings World

    Latest Breaking News From Coatings World

    Keyland Polymer UV Powder, LLC Launches UVMax Defender
    Scott McLaughlin to Race in PPG Colors During Rookie INDYCAR Season
    Vink Chemicals Offers parmetol PSG
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Butterfly Network Appoints New Leader
    BD Names Chairman of Board
    Interplex Acquires OCP Group
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Adare Pharma Solutions Opens New Small-Scale Lab
    Stevanato Group Launches After-sales Service Offering
    X-Chem Acquires IntelliSyn and AviSyn
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Estée Lauder Companies Announces Game-Changing Sustainability Goals for Travel Retail
    Aura Introduces Customizable Hair Care
    Corpack Creates Custom Packaging for Marlies Möller Hair Care Line
    Happi

    Latest Breaking News From Happi

    Nice-Pak Receives EPA Approval for Disinfectant Wipes
    FDA Takes Major Action on Hand Sanitizers from Mexico
    Symrise Shares 2020 Sales Figures
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Great Lakes Label debuts new website
    Epson partner creates label applicators for pharmaceutical products
    ACTEGA removes chemicals from laminating adhesives
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    American Made Production Equipment for Mask Manufacturers
    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements' Lucent XP-Curved Expandable TLIF Gains FDA Nod
    FDA OKs OrthoSpin's 2nd Gen Robotic, Digital External Fixation System
    Nextremity Solutions Enters Supply Agreement with Fort Wayne Metals
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    North American Semiconductor Equipment Industry Posts December 2020 Billings
    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    PRINTING United Alliance Announces TAGA Presents Virtual Event

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login